4.0 Article

The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p

Related references

Note: Only part of the references are listed.
Article Respiratory System

CFTR-beyond the airways: Recent findings on the role of the CFTR channel in the pancreas, the intestine and the kidneys

Peter Hegyi et al.

Summary: With the increase in life expectancy of cystic fibrosis patients and the availability of lung transplantation facilities, the implications of defective CFTR in organs other than the airways have become more prominent. This mini-review focuses on recent scientific progress in understanding CFTR function in the pancreas, intestine, and kidney, and explores potential therapeutic strategies to address CFTR dysfunction in these organs.

JOURNAL OF CYSTIC FIBROSIS (2023)

Article Multidisciplinary Sciences

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

Valentino Bezzerri et al.

Summary: As an inherited disorder characterized by severe pulmonary disease, cystic fibrosis could be considered a comorbidity for coronavirus disease 2019. However, current clinical evidence suggests that cystic fibrosis may actually protect against SARS-CoV-2 infection. The expression of SARS-CoV-2 receptors in primary airway epithelial cells is regulated by the CFTR channel, and dysfunctional CFTR channels in cystic fibrosis cells result in reduced viral entry and replication.

NATURE COMMUNICATIONS (2023)

Article Pharmacology & Pharmacy

Pinostrobin inhibits renal CFTR-mediated Cl- secretion and retards cyst growth in cell-derived cyst and polycystic kidney disease rats

Kanlayanee Tonum et al.

Summary: This study demonstrates the potential therapeutic application of pinostrobin in polycystic kidney disease (PKD) by reducing renal cyst expansion through inhibition of cell proliferation and CFTR-mediated Cl(-) secretion.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2022)

Article Food Science & Technology

A Potent Inhibitor of the Cystic Fibrosis Transmembrane Conductance Regulator Blocks Disease and Morbidity Due to Toxigenic Vibrio cholerae

Fabian Rivera-Chavez et al.

Summary: Vibrio cholerae uses its toxin to cause cholera, but a study found that a compound called benzopyrimido-pyrrolo-oxazinedione (BPO-27) can inhibit the toxin-induced symptoms, protecting mice from diarrhea and death. BPO-27 also suppresses the replication and survival of V. cholerae in the gut.

TOXINS (2022)

Article Oncology

High cystic fibrosis transmembrane conductance regulator expression in childhood B-cell acute lymphoblastic leukemia acts as a potential therapeutic target

Mingfeng Liu et al.

Summary: This study found that high expression of CFTR is associated with childhood B-ALL, and the CFTR inhibitor CFTR-inh172 has the potential to treat B-ALL.

TRANSLATIONAL CANCER RESEARCH (2022)

Article Cell Biology

CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells

Virginia Lotti et al.

Summary: People with cystic fibrosis may be at higher risk for severe symptoms of COVID-19, but they have a lower ability to spread SARS-CoV-2. This study found that CFTR is involved in the regulation of SARS-CoV-2 replication, providing new insights into the development of therapeutic strategies for COVID-19.

CELLS (2022)

Review Microbiology

A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time

Nasruddeen Al-Awwal et al.

Summary: This article summarizes the origin, characteristics, symptoms, prevention and treatment methods of COVID-19, as well as the methods for detecting SARS-CoV-2 and the symptoms after COVID-19.

PATHOGENS (2022)

Article Multidisciplinary Sciences

Vasoactive intestinal peptide and cystic fibrosis transmembrane conductance regulator contribute to the transepithelial calcium transport across intestinal epithelium-like Caco-2 monolayer

Mayuree Rodrat et al.

Summary: VIP and CFTR are involved in intestinal calcium transport. These findings support the existence of neurocrine control of intestinal calcium absorption.

PLOS ONE (2022)

Article Biochemistry & Molecular Biology

Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene

Chiara Papi et al.

Summary: The study found that targeting CFTR-regulating microRNAs with antisense PNAs can increase CFTR production. Particularly, highly effective combinations were identified with PNAs targeting miR-145-5p and miR-101-3p in the treatment of Calu-3 cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis

Xianshuo Cheng et al.

Summary: miR-145-5p is considered a tumor suppressor in early stages of colorectal cancer, but functions as an oncogene in advanced stages. It may regulate invasion and metastasis of CRC cells through EMT and the AKT signaling pathway.

BMC CANCER (2022)

Article Chemistry, Medicinal

Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene

Enrica Fabbri et al.

Summary: The study found that selective inhibition of miR-101-3p through PNA can lead to up-regulation of CFTR. NGS analysis showed that inhibition of miR-101-3p may be accompanied by altered expression of certain other miRNAs.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Therapeutic advances of miRNAs: A preclinical and clinical update

Chiranjib Chakraborty et al.

Summary: This review discusses the current status of miRNAs as biopharmaceuticals, the clinical trials of miRNA therapeutics, and recent advancements in the absorption, distribution, metabolism, excretion, and delivery system of miRNAs.

JOURNAL OF ADVANCED RESEARCH (2021)

Article Biochemistry & Molecular Biology

A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1

Anna Tamanini et al.

Summary: Up-regulating the CFTR scaffolding protein NHERF1 using a PNA targeting miR-335-5p could be a potential strategy to increase CFTR expression in bronchial epithelial cells. Further research is needed to verify the effectiveness of this approach in treating cystic fibrosis caused by different mutations in the CFTR gene.

BIOMEDICINES (2021)

Article Immunology

SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity

Aijaz Parray et al.

Summary: This study identified microRNAs (miRNAs) and small nucleolar RNAs (snoRNAs) as potential biomarkers of COVID-19 severity through differential expression analysis of microarray data, and found that they are significantly correlated with white blood cell count, neutrophil count, lymphocyte count, red blood cell count, hemoglobin, etc. The study provides a unique miRNA and snoRNA profile associated with a higher risk of severity in SARS-CoV-2 infected patients, highlighting the importance of these molecules in SARS-CoV-2 infection.

VACCINES (2021)

Article Urology & Nephrology

A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease

Peerachat Veeraphan et al.

Summary: The study showed that a chalcone derivative, CHAL-005, inhibited the growth of MDCK cysts in a dose-dependent manner without cytotoxicity. CHAL-005 also affected various signaling pathways, including CFTR expression, ERK1/2 and mTOR/S6K phosphorylation levels, and activated AMPK expression. These findings indicate that CHAL-005 could be a promising drug candidate for polycystic kidney disease intervention.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2021)

Article Multidisciplinary Sciences

Differential effects on the miRNome of the treatment of human airway epithelial Calu-3 cells with peptide-nucleic acids (PNAs) targeting microRNAs miR-101-3p and miR-145-5p: Next generation sequencing datasets

Jessica Gasparello et al.

Summary: This study investigates the potential alteration of CFTR gene expression by targeting miRNAs and the co-inhibition of certain microRNAs involved in CF and/or CFTR regulation by miR-101-3p and miR-145-5p with PNAs treatment.

DATA IN BRIEF (2021)

Review Medicine, General & Internal

Update and review of adult polycystic kidney disease

Gates B. Colbert et al.

DM DISEASE-A-MONTH (2020)

Article Biotechnology & Applied Microbiology

Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells

Chiara De Santi et al.

MOLECULAR THERAPY (2020)

Article Cell Biology

CFTR promotes malignant glioma development via up-regulation of Akt/Bcl2-mediated anti-apoptosis pathway

Minyue Zhao et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Environmental Sciences

Particulate Matter Decreases Intestinal Barrier-Associated Proteins Levels in 3D Human Intestinal Model

Brittany Woodby et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Letter Pediatrics

Does cystic fibrosis constitute an advantage in COVID-19 infection?

Valentino Bezzerri et al.

ITALIAN JOURNAL OF PEDIATRICS (2020)

Review Dermatology

MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy

Rebecca Kohnken et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)

Review Genetics & Heredity

The Potential for microRNA Therapeutics and Clinical Research

Johora Hanna et al.

FRONTIERS IN GENETICS (2019)

Article Biotechnology & Applied Microbiology

A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression

Rajib K. Dutta et al.

MOLECULAR THERAPY (2019)

Letter Critical Care Medicine

Enhancing the Expression of CFTR Using Antisense Molecules against MicroRNA miR-145-5p

Alessia Finotti et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Medicine, Research & Experimental

Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle

Jessica Gasparello et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Article Critical Care Medicine

MicroRNA-145 Antagonism Reverses TGF-beta Inhibition of F508del CFTR Correction in Airway Epithelia

Farruk Lutful Kabir et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Pharmacology & Pharmacy

A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas

Paradorn Muangnil et al.

BIOCHEMICAL PHARMACOLOGY (2018)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Medicine, Research & Experimental

Steviol stabilizes polycystin 1 expression and promotes lysosomal degradation of CFTR and β-catenin proteins in renal epithelial cells

Chaowalit Yuajit et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Biochemistry & Molecular Biology

CFTR is a tumor suppressor gene in murine and human intestinal cancer

B. L. N. Than et al.

ONCOGENE (2016)

Article Biotechnology & Applied Microbiology

Insights into the miRNA regulations in human disease genes

Jyotirmoy Das et al.

BMC GENOMICS (2014)

Article Biochemistry & Molecular Biology

Post-Transcriptional Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Expression and Function by MicroRNAs

Shyam Ramachandran et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)

Article Pharmacology & Pharmacy

Antidiarrheal efficacy of a quinazolin CFTR inhibitor on human intestinal epithelial cell and in mouse model of cholera

Jenvit Patanayindee et al.

INDIAN JOURNAL OF PHARMACOLOGY (2012)

Article Multidisciplinary Sciences

MiR-101 and miR-144 Regulate the Expression of the CFTR Chloride Channel in the Lung

Fatemat Hassan et al.

PLOS ONE (2012)

Article Multidisciplinary Sciences

A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulator

Shyam Ramachandran et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Genetics & Heredity

MicroRNAs in Common Human Diseases

Yu Li et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2012)

Article Biochemistry & Molecular Biology

microRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene

Austin E. Gillen et al.

BIOCHEMICAL JOURNAL (2011)

Article Urology & Nephrology

Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease

Baoxue Yang et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)

Article Multidisciplinary Sciences

An Analysis of Human MicroRNA and Disease Associations

Ming Lu et al.

PLOS ONE (2008)

Review Developmental Biology

MicroRNA functions in animal development and human disease

I Alvarez-Garcia et al.

DEVELOPMENT (2005)

Review Biochemistry & Molecular Biology

Silence from within: Endogenous siRNAs and miRNAs

EJ Sontheimer et al.

Review Genetics & Heredity

Micrornas: Small RNAs with a big role in gene regulation

L He et al.

NATURE REVIEWS GENETICS (2004)